本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

諾和諾德

90.86
+3.363.84%
盤前88.83-2.0300-2.23%04:33 EST
成交量:801.17萬
成交額:7.28億
市值:4,033.32億
市盈率:28.92
高:91.90
開:91.50
低:90.29
收:87.50
資料載入中...

公司資料

公司名字:
諾和諾德
交易所:
NYSE
成立時間:
1923
員工人數:
76826
公司地址:
Novo Alle 1,Bagsvaerd,Capital Region of Denmark,Denmark
郵編:
2880
傳真:
- -
簡介:
Novo Nordisk A/S成立於1989年,由兩家丹麥公司Nordisk Gentofte A/S和Novo Industri A/S合併而成。該公司是一家全球醫療保健公司,也是糖尿病和肥胖症護理領域的全球領導者。該公司擁有廣泛的糖尿病和肥胖症護理以及罕見疾病產品組合,包括用於治療糖尿病和肥胖症的胰高血糖素樣肽-1(GLP-1)受體激動劑、現代胰島素和人胰島素。

董事

名稱
職位
Laurence Debroux
Chair of the Board
Andreas Fibig
Director
Christina Law
Director
Elisabeth Dahl Christensen
Director
Henrik Poulsen
Director
Jeppe Christiansen
Director
Kasim Kutay
Director
Liselotte Hyveled
Director
Martin Mackay
Director
Mette Bojer Jensen
Director
Sylvie Gregoire
Director
Thomas Rantzau
Director

股東

名稱
職位
Camilla Sylvest
Executive vice president, Commercial Strategy & Corporate Affairs
David Moore
Executive vice president, U.S. Operations & Business Development
Henrik Wulff
Executive vice president, Product Supply, Quality & IT
Karsten Munk Knudsen
Executive vice president and chief financial officer
Lars Fruergaard Jorgensen
President and chief executive officer
Ludovic Helfgott
Executive vice president, Rare disease
Marcus Schindler
Executive vice president, Research & Early Development and chief scientific officer
Martin Holst Lange
Executive vice president, Development
Maziar Mike Doustdar
Executive vice president, International Operations
Tania Sabroe
Executive vice president, People & Organisation